Inclinix Overview
- Founded
-
1999

- Status
-
Acquired/Merged
- Employees
-
75

- Latest Deal Type
-
M&A
- Financing Rounds
-
3
- Investments
-
1
Inclinix General Information
Description
Provider of clinical trial recruitment services. The company provides strategic medical marketing communications and adherence services to the healthcare industry.
Contact Information
Website
www.inclinix.com
Formerly Known As
PharmaTech Solutions
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Other Healthcare Services
Other Industries
Human Capital Services
Acquirer
Primary Office
- 3534 South College Road
- Suite One
- Wilmington, NC 28412
- United States
+1 (910) 000-0000
Inclinix Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Inclinix Patents
Inclinix Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20050203776-A1 | Method of identifying clinical trial participants | Inactive | 15-Mar-2004 | 000000000 | |
US-20050010544-A1 | Expert system platform | Active | 10-Jul-2003 | 000000000 | |
US-7330842-B2 | Expert system platform | Inactive | 10-Jul-2003 | G16H50/20 |
Inclinix Executive Team (6)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Leo Andron Ph.D | Chief Scientific Officer | ||
Christopher Sleat | Chief Operating Officer | ||
Joel Lanik | Executive Director |
Inclinix Signals
Inclinix Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Inclinix Investments (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
000 00000000 | 06-Jun-2012 | 0000000000 | Laboratory Services (Healthcare) | 0000 0000 |
Inclinix Exits (1)
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
000 00000000 | 06-Jun-2012 | 0000000000 | Completed |
|